Diagnostic Features and Literature Review of Acute Coronary Syndrome Induced by Fluorouracil

Wang Chunhui,Li Jing,Wu Wei,Lin Jinyi,Xu Yuchen,Lyu Qianzhou,Cheng Leilei
DOI: https://doi.org/10.3877/cma.j.issn.2095-655x.2019.03.003
2019-01-01
Abstract:Objective To explore the diagnostic features of acute coronary syndrome induced by fluorouracil. Methods A case of acute coronary syndrome after fluorouracil chemotherapy who was treated for colon cancer in the oncology department of Zhongshan Hospital Affiliated to Fudan University was retrospectively analyzed, the relevant literatures were reviewed. Results A 60-year-old male colon cancer patient combined with coronary heart disease who underwent percutaneous coronary intervention accepted the first cycle adjuvant chemotherapy FOLFOX (fluorouracil, calcium folinate, oxaliplatin) regimen. On the 14th day after chemotherapy, he developed chest tightness, persistent chest pain, inability to lie flat, sitting breathing and shortness of breath. Both serum cardiac troponin (cTnT) level (0.687 μg/L) and N-terminal pro B-type natriuretic (NT-proBNP) level (7 128 ng/L) increased significantly, ECG revealed persistent myocardial ischemia changes and pulmonary CTA showed no definite embolism signs. Excluding other pathological and drug factors, acute coronary syndrome caused by fluorouracil was considered. After the symptomatic supportive treatment, the levels of cTnT and NT-proBNP reduced gradually while the patient no longer complained of chest tightness or chest pain. The surveillance of ECG and TTE during and after TOMOX(oxaliplatin, raltitrexed) regimen had no difference and the level of cTnT decreased to the normal. Conclusion Patients receiving fluorouracil should be monitored carefully of drug-induced cardiotoxicity, such as acute coronary syndrome, to ensure the smooth progress of chemotherapy. Key words: Fluorouracil; Chemotherapy, adjuvant; Acute coronary syndrome; Coronary heart disease; Colon cancer
What problem does this paper attempt to address?